Ultra Chiron Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 0.20 M
as on 03-07-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -7.96%
(FY 2022)
- Profit 24.82%
(FY 2022)
- Ebitda 573.26%
(FY 2022)
- Net Worth -178.16%
(FY 2022)
- Total Assets -15.97%
(FY 2022)
About Ultra Chiron Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Mitesh Kumar, Harjinder Kaur, and Sanjeev Kumar serve as directors at the Company.
- CIN/LLPIN
U24230PB2004PTC027270
- Company No.
027270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Punjab, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ultra Chiron Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mitesh Kumar  | Director | 18-Jan-2010 | Current |
| Harjinder Kaur | Director | 21-Jun-2006 | Current |
| Sanjeev Kumar | Director | 02-Jul-2004 | Current |
Financial Performance and Corporate Structure Insights of Ultra Chiron Healthcare.
Ultra Chiron Healthcare Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.96% decrease. The company also saw a substantial improvement in profitability, with a 24.82% increase in profit. The company's net worth observed a substantial decline by a decrease of 178.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ultra Chiron Healthcare?
In 2022, Ultra Chiron Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ultra Chiron Pharmaceuticals Pvt LtdActive 31 years 5 monthsMitesh Kumar and Sanjeev Kumar are mutual person
Oasis Pharma And Phytomolecules Private LimitedActive 17 years 7 monthsSanjeev Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ultra Chiron Healthcare?
Unlock and access historical data on people associated with Ultra Chiron Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ultra Chiron Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultra Chiron Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
